Our results revealed that melatonin modulated multiple changes induced by doxorubicin, and we found, for the first time, that melatonin counteracted the stimulatory effect of doxorubicin on the expression of TWIST1 in breast cancer cells. The gene discussed is TWIST1; the disease is breast cancer.